检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:戴小灵[1] 侯志琴[1] 朱兴华[2] 何小珊[1] 钟远辉[1]
机构地区:[1]梅州市人民医院感染科,广东梅州514031 [2]梅州市人民医院血透中心,广东梅州514031
出 处:《医学综述》2015年第14期2678-2680,共3页Medical Recapitulate
摘 要:目的研究血浆置换(PE)联合持续性血液透析滤过(CHDF)治疗重型肝炎的效果。方法将2011年2月至2014年5月梅州市人民医院感染科收治的120例重型肝炎患者按照随机数字表法分为三组:A组(38例)采用PE+综合内科治疗,B组(42例)采用PE+CHDF+综合内科治疗,C组(40例)采用综合内科治疗。比较各组的临床疗效、生化指标变化及近期生存率情况。结果 B组总有效率为95.2%,明显高于A组(68.4%)和C组(52.5%)(P<0.01)。治疗后三组患者肝肾功能等生化指标均较治疗前改善,且B组改善程度最大(P<0.01),而A组改善程度较C组明显(P<0.01)。B组症状改善率为100.0%,明显高于A组(73.7%)和C组(45.0%)(P<0.01)。B组患者生存率为78.6%,明显高于A组(47.6%)和C组(35.0%)(P<0.01)。结论 PE联合CHDF治疗重型肝炎,疗效确切,可有效改善临床症状和肝肾功能,提高近期生存率,改善患者预后。Objective To study the effect of plasmapheresis ( PE ) and continuous hemodialysis filtra-tion ( CHDF) for the treatment of severe hepatitis.Methods A total of 120 patients with severe hepatitis admitted to the Guangdong Meizhou People′s Hospital from Feb.2011 to May 2014 were divided into group A,B,C according to random-number table method.Group A:38 cases,using PE +comprehensive medical treatment;group B:42 cases,using PE +CHDF +comprehensive medical treatment;group C:40 cases, with comprehensive medical treatment.The clinical efficacy,changes of biochemical indicators and short-term survival rate of the three groups were observed.Results After treatment,the effect of group B(95.2%) was highest and significantly higher than that in group A(68.4%)and group C(52.5%)(P〈0.01).The liver and kidney functions of the three groups such as biochemical index was improved from before treatment ,and group B had the most significant improvement (P〈0.01),group A was better than group C(P〈0.01).The symptoms improvement of group B ( 100.0%) was obviously higher than that of group A ( 73.7%) and group C (45.0%)(P〈0.01).Group B′s survival rate(78.6%)was obviously higher than that of group A (47.6%) and group C(35.0%)(P〈0.01).Conclusion PE combined with CHDF treating severe hepa-titis has a good curative effect,and can effectively improve the clinical symptoms,the function of liver and kidney,the recent survival rate and the prognosis.
分 类 号:R55[医药卫生—血液循环系统疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.28